ODN 1826 sodium is a class B CpG ODN (oligodeoxynucleotide) and TLR9 agonist. ODN 1826 sodium induces NO and iNOS production and enhances Apoptosis. ODN 1826 sodium enhances immune surveillance. ODN 1826 sodium increases aortic atherosclerotic plaque size. ODN 1826 sodium has antitumor activity against lung cancer, glioma and melanoma[1][2][3][4][5][6].
Smiles
[ODN1826(sodium)]
Target
Apoptosis; NO Synthase; Toll-like Receptor (TLR)
Isoform
TLR9
Purity
99.51
Solubility
10 mM in H2O
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
